An array of target-specific screening strains for antibacterial discovery

Area of Science:

• Microbiology
• Drug Discovery
• Genetics Engineering

Background:

• Rising global threat of drug- and antibiotic-resistant bacteria necessitates novel antimicrobial discovery strategies.
• Existing drug discovery methods require advancement to address resistance.
• Essential gene products are key targets for antimicrobial intervention.

Purpose of the Study:

• To construct an array of engineered Escherichia coli strains for efficient whole-cell screening.
• To identify new antimicrobial compounds targeting essential bacterial genes.
• To validate the specificity and efficacy of the screening approach.

Main Methods:

• Engineered Escherichia coli strains using bacteriophage lambda and P1 recombination systems.
• Created strains with low-level expression of single essential gene products for hypersusceptibility.
• Screened nine engineered strains in parallel against a large chemical library.
• Validated identified inhibitors using in vitro biochemical assays.

Main Results:

• Successfully constructed an array of hypersusceptible Escherichia coli strains.
• Identified novel inhibitors of bacterial growth through whole-cell screening.
• Demonstrated target specificity, with identified MurA inhibitors blocking in vitro biochemical function.
• The screening approach proved effective in discovering specific antimicrobial compounds.

Conclusions:

• The engineered Escherichia coli strain array is a powerful tool for identifying novel antimicrobial compounds.
• This hypersusceptibility-based screening strategy accelerates the drug discovery process.
• The approach offers high target specificity, facilitating the development of new antibiotics.